Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation
Haematologica. 2024 Nov 28.
doi: 10.3324/haematol.2024.286265.
Online ahead of print.
1 Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing.
2 School of Medicine, Shanghai University, Shanghai 200444, China; State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases.
3 The Fifth Medical Center of Chinese PLA General Hospital, East St 8th, Fengtai District, Beijing.
4 School of Medicine, Shanghai University, Shanghai 200444.
5 Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Peking-Tsinghua Center for Life Sciences, Beijing. huangxiaojun@bjmu.edu.cn.